| Disease | SIXTY INPATIENTS WITH CEREBRAL INSUFFICIENCY AND DEPRESSIVE MOOD, WERE TREATED IN A DOUBLE-BLIND STUDY FOR 6 WEEKS WITH A DAILY DOSE OF 160 MG GINKGO BILOBA EXTRACT OR PLACEBO. AFTER 2, 4 AND 6 WEEKS, CHANGES IN 12 TYPICAL SYMPTOMS IN COMPARISON
WITH THE LAST EXAMINATION, WERE EVALUATED. IN THE GROUP RECEIVING PLACEBO, SMALL, BUT PROGRESSIVE IMPROVEMENTS WERE OBSERVED. IN THE GINKGO-BILOBA GROUP, THE OVERALL NUMBER OF IMPROVEMENTS WAS SIGNIFICANTLY LARGER. AFTER 2 WEEKS THE DIFFERENCES
WERE MARKED FOR ONLY A FEW OF THE SYMPTOMS; AFTER 4 AND 6 WEEKS IN CONTRAST, IN 11 OF THE 12 SYMPTOMS. THE LARGEST NUMBER OF IMPROVEMENTS IN THE GINKGO-BIOLBA GROUP WAS OBSERVED BETWEEN THE 2ND AND 4TH WEEKS OF TREATMENT. IN THIS PERIOD, ABOUT
TWO-THIRDS OF THE PATIENTS ON GINKGO-BIOLBA, AND ABOUT ONE-FIFTH OF THE PATIENTS ON PLACEBO SHOWED IMPROVEMENTS. EGB-761 WAS USED. |